Safety Shot Amends 8-K: Warrants Exercisable at $8.50/Share

Ticker: BNKK · Form: 8-K/A · Filed: Feb 6, 2024 · CIK: 1760903

Safety Shot, INC. 8-K/A Filing Summary
FieldDetail
CompanySafety Shot, INC. (BNKK)
Form Type8-K/A
Filed DateFeb 6, 2024
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$8.50
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: warrants, amendment, dilution-risk

TL;DR

**SHOT clarified warrant terms: $8.50 exercise price, watch for dilution.**

AI Summary

Safety Shot, Inc. (SHOT) filed an 8-K/A on February 6, 2024, amending its January 16, 2024 report to clarify the terms of warrants issued. The amendment specifies that each warrant is exercisable for one share of common stock at $8.50 per share. This matters to investors because it provides precise details on potential dilution and future capital raises, impacting the value of existing shares.

Why It Matters

This amendment clarifies the terms of warrants, which could lead to dilution if exercised, impacting the per-share value for current shareholders.

Risk Assessment

Risk Level: medium — The existence of warrants at a specific exercise price introduces potential future dilution, which can negatively impact existing shareholders.

Analyst Insight

Investors should monitor the company's stock price relative to the $8.50 warrant exercise price. If the stock trades significantly above this, warrant holders may exercise, leading to increased share count and potential dilution. This filing provides clarity but doesn't inherently change the company's fundamentals.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 8-K/A filing by Safety Shot, Inc.?

This 8-K/A filing is an Amendment No. 1 to a previous Current Report, specifically to clarify information regarding warrants. It was filed on February 6, 2024, amending the report from January 16, 2024.

What specific detail about the warrants was clarified in this amendment?

The amendment clarified that each warrant is exercisable for one share of common stock at an exercise price of $8.50 per share, as stated in the filing under 'SHOT:WarrantsEachExercisableForOneShareOfCommonStockAt8.50PerShareMember'.

What is Safety Shot, Inc.'s CIK number and state of incorporation?

Safety Shot, Inc.'s Central Index Key (CIK) is 0001760903, and it is incorporated in Delaware.

What was Safety Shot, Inc.'s former company name before Jupiter Wellness, Inc.?

Before Jupiter Wellness, Inc. (name changed on 20200615), Safety Shot, Inc. was formerly known as CBD Brands, Inc., with that name change occurring on 20181206.

What is the business address and phone number for Safety Shot, Inc.?

The business address for Safety Shot, Inc. is 1061 E. Indiantown Rd., Ste. 110, Jupiter, FL 33477, and their business phone number is (561) 244-7100.

Filing Stats: 745 words · 3 min read · ~2 pages · Grade level 8.8 · Accepted 2024-02-06 16:11:05

Key Financial Figures

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K/A ( Amendment No. 1 ) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2024 SAFETY SHOT, INC. (Exact name of registrant as specified in charter) Delaware 001-39569 83-2455880 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 1061 E. Indiantown Rd. , Ste. 110 , Jupiter , FL 33477 (Address of principal executive offices) (Zip Code) (561) 244-7100 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock SHOT The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Warrants, each exercisable for one share of Common Stock at $8.50 per share SHOTW The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Explanatory Note This Amendment No. 1 on Form 8-K ("Amendment No. 1") amends Exhibit 99.3 of the Form 8-K filed by Safety Shot, Inc. (the "Company") on January 16, 2024 (the "January 16 Form 8-K") in which the Company served its summons and complaint upon Capybara Research and Igor Appelboom via the filing of the January 16 Form 8-K and the publication of a press release, attached to the January 16 Form 8-K as Exhibit 99.1, pursuant to an Order in the matter of Safety Shot, Inc. v. Capybara Research et. al. , Case No. 1:23-cv-10728-JSR (the "Capybara Action"). This Amendment No. 1 hereby amends Exhibit 99.3 of the January 16 Form 8-K to rectify an error in the upload of the original Exhibit 99.3 to the January 16 Form 8-K. The text and Exhibits 99.1, 99.2 and 99.4 of the January 16 Form 8-K are hereby incorporated by reference and contained hereinafter. Item 7.01 Regulation FD Disclosure On January 16, 2024, the Company issued a press release. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference. Item 8.01 Other Events On January 10, 2024, The Honorable Jed S. Rakoff in the United States District Court for the Southern District of New York, entered an Order in the matter of Safety Shot, Inc. v. Capybara Research et. al. , Case No. 1:23-cv-10728-JSR (the "Capybara Action"), ECF 24 (the Order"), permitting the Company to serve its summons and complaint upon Defendants Capybara Research and Igor Appelboom by filing this Form 8-K and publishing the press release, attached hereto as Exhibit 99.1. Pursuant to the Order, the filing of this Form 8-K, the summons attached hereto as Exhibit 99.2, the complaint attached hereto as Exhibit 99.3 and the Order attached hereto as Exhibit 99.4 shall provide the Constitutional requirement of actual notice of the Action to Defendants Capybara Research and Igor Appelboom pursuant to Rule 4(f)(3) of the Federal Rules of Civil Procedure. Exhibits 9.01 Financial Statements and Exhibits Exhibit No. Description 99.1 Press Release dated January 16, 2024 99.2 Summons 99.3 Complaint 99.4 Order 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 6, 2024 SAFETY SHOT, INC. By: /s/ Brian John Brian John Chief Executive Officer

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing